The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health

Publication Title

New England Journal of Medicine

Authors

Jonathan J. Darrow
Erin C. Fuse Brown, Georgia State University College of LawFollow
Aaron S. Kesselheim, Brigham and Women's Hospital, Harvard Medical SchoolFollow

Document Type

Article

Publication Date

2-1-2018

Comments

External Links

Westlaw

Recommended Citation

Jonathan J. Darrow, Erin C. Fuse Brown, & Aaron S. Kesselheim, The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health, 378 N. Eng. J. Med. 412 (2018).

Institutional Repository Citation

Jonathan J. Darrow, Erin C. Fuse Brown & Aaron S. Kesselheim, The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health, Faculty Publications By Year 2588 (2018)
https://readingroom.law.gsu.edu/faculty_pub/2588

DOI

10.1056/NEJMp1711643

Volume

378

First Page

412

Last Page

414